Sunovion To Lay Down Up To $430M For Elevation Pharma
Sunovion Pharmaceuticals Inc. has agreed to pay up to $430 million to buy San Diego-based respiratory drugmaker Elevation Pharmaceuticals Inc. in a deal that includes its chronic obstructive pulmonary disease treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article